ArticleArthritis research & therapy2026

Risk of serious infections, myocardial infarction or stroke, venous thromboembolic events, and malignancy in patients with psoriatic arthritis treated with tofacitinib compared with biologic treatments in the United States.

Marina Magrey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.